A man receives a dose of Sinovac COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech in Bandar Sunway near Kuala Lumpur, Malaysia, April 22, 2021. Malaysia reported 2,875 new COVID-19 infections, the Health Ministry said on Thursday, bringing the national total to 384,688. (Photo by Chong Voon Chung/Xinhua)
A medical worker displays used bottles of Sinovac COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech in Bandar Sunway near Kuala Lumpur, Malaysia, April 22, 2021. Malaysia reported 2,875 new COVID-19 infections, the Health Ministry said on Thursday, bringing the national total to 384,688. (Photo by Chong Voon Chung/Xinhua)
A medical worker prepares a dose of Sinovac COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech in Bandar Sunway near Kuala Lumpur, Malaysia, April 22, 2021. Malaysia reported 2,875 new COVID-19 infections, the Health Ministry said on Thursday, bringing the national total to 384,688. (Photo by Chong Voon Chung/Xinhua)
People wait to receive COVID-19 vaccines in Bandar Sunway near Kuala Lumpur, Malaysia, April 22, 2021. Malaysia reported 2,875 new COVID-19 infections, the Health Ministry said on Thursday, bringing the national total to 384,688. (Photo by Chong Voon Chung/Xinhua)